Literature DB >> 24867840

Migraine and the menopausal transition.

Vincent T Martin1.   

Abstract

The menopausal transition or "perimenopause" represents a time period of turbulent changes in ovarian hormones as middle-aged women progress into menopause. The purpose of this article is to review the literature to determine the effect of the menopausal transition on migraine headaches and to develop a rational treatment approach to these patients. The menopausal transition is divided into early and stages based upon patterns of menstruation and specific reproductive hormones. Studies would suggest that the prevalence of migraine and other climacteric symptoms tend to peak during the late menopausal transition particularly in those with a past history of premenstrual stress disorder. Treatment approaches vary by stage of the menopausal transition and include conventional daily preventatives, mini-prophylaxis and hormonal therapies.

Entities:  

Mesh:

Year:  2014        PMID: 24867840     DOI: 10.1007/s10072-014-1745-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  48 in total

1.  Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.

Authors:  Janet S Carpenter; Anna Maria Storniolo; Shelley Johns; Patrick O Monahan; Faouzi Azzouz; Julie L Elam; Cynthia S Johnson; Richard C Shelton
Journal:  Oncologist       Date:  2007-01

2.  Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study.

Authors:  K L Aegidius; J-A Zwart; K Hagen; B Schei; L J Stovner
Journal:  Eur J Neurol       Date:  2007-01       Impact factor: 6.089

3.  Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches.

Authors:  Rossella E Nappi; Grazia Sances; Arianna Sommacal; Silvia Detaddei; Fabio Facchinetti; Silvano Cristina; Franco Polatti; Giuseppe Nappi
Journal:  Menopause       Date:  2006 Sep-Oct       Impact factor: 2.953

4.  Factors influencing the age at natural menopause.

Authors:  J L Stanford; P Hartge; L A Brinton; R N Hoover; R Brookmeyer
Journal:  J Chronic Dis       Date:  1987

5.  Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.

Authors:  E A MacGregor; A Frith; J Ellis; L Aspinall; A Hackshaw
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

6.  The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.

Authors:  John F Randolph; MaryFran Sowers; Irina Bondarenko; Ellen B Gold; Gail A Greendale; Joyce T Bromberger; Sarah E Brockwell; Karen A Matthews
Journal:  J Clin Endocrinol Metab       Date:  2005-09-06       Impact factor: 5.958

7.  Symptoms in the menopausal transition: hormone and behavioral correlates.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

8.  A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.

Authors:  Stephen D Silberstein; Arthur H Elkind; Curtis Schreiber; Charlotte Keywood
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

9.  Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache.

Authors:  Vincent Martin; Suzanne Wernke; Karen Mandell; Willie Zoma; Judy Bean; Susan Pinney; James Liu; Nabih Ramadan; Robert Rebar
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

10.  Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Constance Chen; Julie E Buring; Guillaume Paré; Susan E Hankinson; Stephen J Chanock; Paul M Ridker; David J Hunter; Daniel I Chasman
Journal:  Nat Genet       Date:  2009-05-17       Impact factor: 38.330

View more
  7 in total

1.  Correlation analysis for follicle-stimulating hormone and C-terminal cross-linked telopetides of type i collagen in menopausal transition women with osteoporosis.

Authors:  Bing Wang; Yang Song; Yan Chen; En-Sheng Wang; Dan Zheng; Fan Qu; Jian-Hong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Current Treatment Options: Headache Related to Menopause-Diagnosis and Management.

Authors:  Clinton G Lauritsen; Abigail L Chua; Stephanie J Nahas
Journal:  Curr Treat Options Neurol       Date:  2018-03-06       Impact factor: 3.598

Review 3.  Migraine in perimenopausal women.

Authors:  G Allais; G Chiarle; F Bergandi; C Benedetto
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 4.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 5.  Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines.

Authors:  Lorena Dima; Andreea Bălan; Marius Alexandru Moga; Cătălina Georgeta Dinu; Oana Gabriela Dimienescu; Ioana Varga; Andrea Elena Neculau
Journal:  Toxins (Basel)       Date:  2019-08-08       Impact factor: 4.546

6.  Allostatic Load in Perimenopausal Women With Migraine.

Authors:  Pamela Alebna; Nasim Maleki
Journal:  Front Neurol       Date:  2021-04-22       Impact factor: 4.003

7.  Structural and functional brain changes in perimenopausal women who are susceptible to migraine: a study protocol of multi-modal MRI trial.

Authors:  Bo Hu; Xu Wang; Jie-Bing He; Yu-Jie Dai; Jin Zhang; Ying Yu; Qian Sun; Yu-Chuan Hu; Hai-Yan Nan; Yang Yang; Alan D Kaye; Guang-Bin Cui; Wen Wang
Journal:  BMC Med Imaging       Date:  2018-09-06       Impact factor: 1.930

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.